BMI and TLC Influences Doxorubicin/Epirubicin Neoadjuvant Chemotherapy Response in Patients with Locally Advanced Breast Cancer. MKB [Internet]. 2022 Dec. 31 [cited 2026 Jul. 6];54(4):221-7. Available from: https://beta.unpadmedjournals.id/index.php/mkb/article/view/2797